Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabetes Claim Warnings Signal Spread Of Violative Products

This article was originally published in The Tan Sheet

Executive Summary

CDER says a product marketed as a supplement contains three pharmaceutical ingredients, including phenformin, banned in 1978 because of the occurrence of lactic acidosis in patients. Trade group executives say warnings to 14 firms making diabetes and other disease claims demonstrate that noncompliant businesses will target more health conditions of growing concern to consumers.

Advertisement

Related Content

Mannatech Makes Hash Of Ingredient Identities In Label, Online Claims
Supplement's Noncompliant Diabetes Claims Also Fail NAD Review
Spiked “Supplements” For Diabetes, Pain On The Rise

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106520

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel